jame
duke
md
mba
chapter
would
knowledg
oxygen
deliveri
impact
decis
transfus
transfus
would
indic
oxygen
deliveri
fall
critic
level
oxygen
consumpt
vo
need
met
recal
function
cardiac
output
co
arteri
oxygen
content
cao
arteri
oxygen
content
function
arteri
oxygen
satur
oxygencarri
capac
hemoglobin
hemoglobin
concentr
amount
oxygen
dissolv
blood
unbound
hemoglobin
partial
pressur
oxygen
ordinarili
exce
vo
factor
four
mlmin
vs
mlmin
thu
extract
ratio
er
vo
long
exce
vo
vo
suppli
independ
howev
vo
becom
suppli
depend
vo
decreas
decreas
creat
situat
endorgan
risk
ischemia
point
transfus
clearli
indic
long
patient
euvolem
reach
hemoglobin
decreas
gdl
also
requir
pulmonari
function
intact
sinc
requir
full
hemoglobin
oxygen
satur
oxygen
dissolv
blood
bound
hemoglobin
note
hemoglobin
level
oxygen
dissolv
blood
becom
major
contributor
almost
oxygen
deliv
also
mention
modifi
patient
oxygen
requir
baselin
eg
catabol
state
sepsi
burn
presenc
endorgan
diseas
coronari
arteri
diseas
given
cours
normal
oper
room
condit
unavail
variabl
use
determin
whether
patient
transfus
includ
hypotens
tachycardia
urin
output
presenc
lactic
acidosi
sign
myocardi
ischemia
new
stsegment
depress
mv
new
stsegment
elev
mv
region
wall
motion
abnorm
echocardiographi
low
mix
venou
oxygen
satur
requir
pulmonari
arteri
catheter
determin
surgeri
acut
blood
loss
usual
replac
crystalloid
solut
suffici
volum
result
acut
normovolem
hemodilut
compensatori
chang
includ
sympathet
stimul
result
tachycardia
increas
cardiac
output
decreas
viscos
reduc
afterload
increas
preload
improv
flow
capillari
level
sinc
capillari
flow
maxim
rest
condit
capillari
recruit
adapt
mechan
well
addit
redistribut
blood
tissu
oxygen
suppli
depend
eg
heart
brain
oxygen
extract
increas
import
note
myocardi
oxygen
extract
high
normal
circumst
thu
reserv
less
brain
greater
extract
reserv
heart
thu
heart
depend
increas
blood
flow
increas
oxygen
deliveri
signific
becom
clear
coronari
arteri
diseas
failur
acut
normovolem
anemia
deliv
oxygen
excess
consumpt
anoth
argument
favor
blood
transfus
histor
hemoglobin
level
gdl
hematocrit
use
transfus
trigger
longer
accept
practic
patient
coronari
arteri
diseas
sign
myocardi
ischemia
level
hemoglobin
might
appropri
otherwis
come
view
liber
transfus
trigger
recal
otherwis
normal
situat
reach
hemoglobin
decreas
gdl
although
clinician
probabl
push
patient
extrem
unless
patient
request
transfus
base
religi
reason
like
less
like
transfus
realli
indic
risk
transfus
neg
impact
riskbenefit
ratio
also
interest
note
men
women
tend
treat
equal
decis
transfus
made
despit
fact
normal
women
anem
rel
men
use
transfus
trigger
hardli
seem
ration
final
concern
transfus
might
substanti
increas
oxygen
deliveri
see
discuss
blood
storag
lesion
question
strong
argument
close
scrutin
consider
transfus
risk
includ
contract
infecti
diseas
transfus
transfus
reaction
immunomodulatori
effect
transfus
infecti
diseas
contract
transfus
signific
risk
point
time
blood
suppli
safe
ever
risk
contract
hepat
human
immunodefici
viru
hiv
develop
nation
estim
million
unit
transfus
donat
blood
test
hepat
b
hepat
b
core
antigen
hepat
c
hepat
c
antibodi
syphili
hiv
human
cell
lymphotrop
viru
west
nile
viru
cytomegaloviru
improv
test
window
donat
seroconvers
becom
increasingli
narrow
howev
new
infecti
risk
includ
contract
prionmedi
diseas
variant
creutzfeldtjakob
diseas
vcjd
parasit
diseas
chaga
diseas
malaria
avian
flu
concern
sever
acut
respiratori
syndrom
eventu
spread
blood
suppli
risk
diseas
vari
geograph
local
instanc
malaria
greater
risk
undevelop
countri
hiv
known
case
contract
vcjd
transfus
unit
kingdom
platelet
store
higher
temperatur
c
red
blood
cell
c
blood
product
platelet
blood
compon
greatest
risk
bacteri
infect
howev
test
sepsi
platelet
unit
improv
risk
like
decreas
time
n
hemolyt
transfus
reaction
caus
abo
incompat
commonli
caus
cleric
error
transfus
wrong
unit
mistransfus
thought
occur
frequenc
reaction
occur
shortli
transfus
clinic
manifest
includ
fever
chill
chest
flank
back
pain
hypotens
nausea
flush
diffus
bleed
oliguria
anuria
hemoglobinuria
gener
anesthesia
may
mask
clinic
manifest
hypotens
hemoglobinuria
diffus
bleed
may
sign
note
sign
sever
hemolyt
reaction
might
miss
patient
gener
anesthesia
attribut
anoth
caus
n
anaphylact
reaction
caus
bind
ige
present
bronchospasm
edema
red
hypotens
requir
urgent
treatment
epinephrin
fluid
infus
corticosteroid
antihistamin
therapi
indic
sever
progress
symptom
n
febril
reaction
may
earli
sign
hemolyt
transfus
reaction
symptom
present
bacteri
contamin
blood
product
febril
nonhemolyt
transfus
reaction
usual
occur
patient
prior
transfus
headach
nausea
malais
associ
symptom
reaction
caus
leukocyt
antibodi
leukocytedeplet
red
blood
cell
may
indic
patient
antipyret
may
decreas
symptom
given
transfus
meperidin
may
decreas
sever
chill
n
transfusionrel
acut
lung
injuri
trali
top
three
transfusionrel
death
mortal
form
noncardiogen
pulmonari
edema
trali
also
immun
relat
usual
note
within
hour
transfus
symptom
includ
hypoxia
dyspnea
fever
pulmonari
edema
treatment
support
n
urticari
reaction
secondari
mast
cell
degranul
requir
transfus
stop
antihistamin
may
given
n
transfus
reaction
compar
tabl
current
standard
length
storag
blood
blood
storag
lesion
feder
regul
requir
least
transfus
red
blood
cell
surviv
hour
day
adsol
nutric
ad
chang
store
blood
reduc
posttransfus
viabil
known
storag
lesion
includ
reduct
red
cell
deform
alter
red
cell
adhes
deplet
adenosin
triphosph
store
reduct
decreas
abil
hemoglobin
dissoci
curv
shift
right
enhanc
peripher
oxygen
releas
proinflammatori
cytokin
accumul
even
week
capabl
significantli
prime
neutrophil
exacerb
inflammatori
respons
convinc
evid
effect
transfus
immun
function
harm
much
evid
immun
modul
infect
relat
transfus
retrospect
natur
suffer
failur
control
confound
variabl
insuffic
number
random
control
studi
suffici
power
studi
exist
conduct
critic
ill
patient
periop
set
perhap
except
patient
coronari
bypass
definit
recommend
await
howev
point
worthi
discuss
transfus
requir
critic
care
trial
suffici
power
evalu
impact
transfus
outcom
group
studi
divid
restrict
transfus
hemoglobin
trigger
gdl
target
hemoglobin
level
gdl
liber
transfus
group
hemoglobin
transfus
trigger
gdl
target
hemoglobin
level
gdl
thirtyday
mortal
lower
restrict
transfus
group
although
statist
signific
p
met
howev
patient
subdivid
acuiti
ill
fewer
acut
ill
patient
restrict
transfus
group
lower
mortal
prospect
studi
less
convinc
find
overlap
transfus
trigger
patient
popul
differ
observ
studi
found
number
transfus
unit
independ
risk
factor
mortal
increas
length
stay
overal
must
said
final
word
impact
transfus
mortal
yet
written
note
mani
countri
routin
perform
leukoreduct
donat
blood
concern
impact
transfus
recipi
immun
function
recent
trali
identifi
lead
caus
transfusionrel
death
unit
state
estim
transfus
result
trali
blood
compon
result
trali
includ
pack
erythrocyt
random
donor
platelet
singl
donor
apheresi
platelet
fresh
frozen
plasma
cryoprecipit
howev
cellular
compon
greater
associ
trali
even
autolog
blood
result
trali
suggest
may
storag
lesion
contribut
etiolog
although
donor
antibodi
shown
present
mani
trali
seri
presenc
neither
necessari
suffici
result
trali
believ
trali
multifactori
twoevent
subtyp
acut
lung
injuri
associ
condit
recipi
high
level
inflammatori
mediat
eg
cytokin
prime
white
blood
cell
pulmonari
endothelium
administ
blood
product
provid
second
event
classic
antibodyantigen
coupl
lipid
product
cytokin
gener
storag
blood
product
prime
white
blood
cell
activ
releas
substanc
superoxid
damag
pulmonari
endothelium
condit
may
predispos
patient
transfusionrel
acut
lung
injuri
condit
associ
trali
includ
sepsi
organ
ischemia
massiv
transfus
extracorpor
circul
malign
recent
surgic
procedur
aspir
gastric
content
neardrown
pneumonia
longbon
fractur
burn
pulmonari
contus
dissemin
intravascular
coagul
obvious
patient
must
ill
enough
requir
transfus
discuss
criteria
diagnosi
transfusionrel
acut
lung
injuri
n
acut
onset
often
occur
less
hour
transfus
usual
less
hour
n
pulmonari
arteri
occlus
pressur
mm
hg
lack
clinic
evid
left
atrial
overload
ie
problem
noncardiogen
pulmonari
edema
n
bilater
infiltr
observ
chest
radiograph
n
hypoxemia
ratio
pao
fio
mm
hg
regardlesss
level
posit
endexpiratori
pressur
oxygen
satur
room
air
n
acut
lung
injuri
exist
prior
transfus
patient
experi
deterior
oxygen
transfus
transfus
discontinu
remaind
transfus
blood
return
laboratori
analysi
cours
form
transfus
injuri
besid
trali
may
take
place
therapi
support
continu
treat
patient
medic
problem
may
prime
event
trali
aggress
pulmonari
support
transfus
need
wise
use
blood
product
reduc
likelihood
inflammatori
mediatior
includ
leukoreduc
pack
erythrocyt
pack
unit
less
day
old
wash
erythrocyt
case
platelet
apheresi
unit
less
day
old
review
abo
rh
blood
genotyp
associ
antibodi
pattern
blood
type
determin
two
allel
three
type
b
b
refer
antigen
red
blood
cell
surfac
individu
either
b
b
neither
blood
type
individu
type
antigen
time
antia
antibodi
also
known
agglutinin
form
patient
type
ab
blood
antigen
form
agglutinin
individu
type
blood
antigen
develop
b
antibodi
tabl
antibodi
primarili
immunoglobulin
ig
igg
acut
hemolyt
reaction
caus
complement
activ
releas
proteolyt
enzym
digest
red
cell
membran
peopl
type
blood
neither
b
antigen
agglutinogen
cell
surfac
cell
agglutin
antibodi
agglutinin
may
present
transfus
recipi
blood
thu
type
blood
known
univers
donor
red
blood
cell
patient
type
ab
blood
class
antigen
agglutinogen
therefor
form
b
antibodi
agglutinin
antibodi
plasma
type
ab
patient
univers
donor
plasma
six
common
antigen
rh
system
presenc
antigen
commonli
refer
rh
posit
rh
blood
type
system
slightli
differ
rh
agglutinin
rare
form
spontan
usual
massiv
exposur
prior
transfus
necessari
stimul
format
rhneg
patient
receiv
rhposit
blood
emerg
situat
although
antibodi
form
patient
may
delay
usual
mild
hemolyt
transfus
reaction
patient
rh
sensit
signific
transfus
reaction
expos
rhposit
blood
later
date
differ
type
screen
crossmatch
patient
blood
type
abo
rh
group
place
red
cell
commerci
avail
antia
antib
reagent
revers
type
patient
serum
b
reagent
cell
screen
antibodi
involv
place
patient
serum
special
select
red
cell
contain
relev
blood
group
antigen
crossmatch
patient
serum
also
incub
small
quantiti
red
cell
propos
donor
unit
verifi
vitro
compat
crossmatch
also
detect
uniqu
antibodi
tabl
type
blood
use
emerg
situat
transfus
emerg
situat
allow
time
complet
crossmatch
circumst
fastest
choic
use
type
rhneg
rh
posit
male
uncrossmatch
blood
two
unit
type
blood
given
patient
type
b
antia
antib
antibodi
type
blood
type
blood
continu
administ
complet
test
patient
blood
ensur
hemolysi
nativ
cell
take
place
typespecif
uncrossmatch
blood
would
next
choic
follow
typespecif
partial
crossmatch
blood
final
fulli
crossmatch
blood
massiv
transfus
defin
administr
one
blood
volum
within
sever
hour
complic
includ
n
coagulopathi
secondari
dilut
thrombocytopenia
lack
labil
coagul
factor
v
viii
dissemin
intravascular
coagul
n
metabol
disturb
associ
bank
blood
includ
hyperkalemia
hypocalcemia
citrat
toxic
acidosi
impair
oxygen
deliveri
caus
reduc
suspect
major
transfus
reaction
manag
n
stop
transfus
immedi
remov
blood
tube
n
alert
blood
bank
send
recipi
donor
blood
specimen
compat
test
n
treat
hypotens
aggress
intraven
fluid
pressor
agent
n
maintain
urin
output
intraven
hydrat
mannitol
loop
diuret
use
occas
n
massiv
hemolysi
result
hyperkalemia
follow
serum
potassium
level
continu
monitor
electrocardiogram
electrocardiograph
sign
hyperkalemia
n
dissemin
intravascular
coagul
may
occur
best
treatment
identifi
treat
underli
caus
follow
prothrombin
partial
thromboplastin
fibrinogen
ddimer
level
n
check
urin
plasma
hemoglobin
level
verifi
hemolysi
direct
antiglobulin
coomb
test
bilirubin
plasma
haptoglobin
level
n
avail
thromboelastographi
increas
use
assess
coagul
disturb
altern
transfus
donor
blood
n
autolog
transfus
collect
reinfus
patient
blood
note
predon
unit
return
patient
patient
schedul
autolog
transfus
still
run
risk
cleric
error
bacteri
infect
also
report
patient
receiv
autolog
transfus
develop
trali
n
preoper
use
erythropoietin
stimul
erythrocyt
product
erythropoietin
stimul
erythrocyt
product
day
shown
reduc
use
allogen
blood
patient
renal
insuffici
anemia
chronic
diseas
transfus
refus
n
intraop
collect
reinfus
blood
lost
surgeri
n
intraop
isovolem
hemodilut
reduct
hematocrit
hemoglobin
withdraw
blood
simultan
intravascular
replac
crystalloid
n
use
hemoglobin
solut
limit
advantag
disadvantag
altern
hemoglobin
solut
benefit
altern
erythrocyt
transfus
includ
lack
antigen
possibl
unlimit
avail
diseas
transmiss
risk
long
storag
life
better
rheolog
properti
two
type
oxygencarri
solut
develop
n
perfluorocarbon
emuls
high
gasdissolv
capac
oxygen
n
hemoglobinbas
oxygen
carrier
discuss
focus
latter
compound
manufactur
human
recombin
hemoglobin
outdat
human
blood
bovin
blood
stromal
compon
erythrocyt
remov
hemoglobin
molecul
polymer
liposom
encapsul
prevent
rapid
renal
excret
nephrotox
cellfre
hemoglobin
solut
two
major
problem
first
low
concentr
lack
shift
oxyhemoglobin
dissoci
curv
left
affin
hemoglobin
oxygen
increas
oxygen
offload
tissu
level
second
nitric
oxid
scaveng
produc
excess
vasoconstrict
pulmonari
hypertens
myocardi
ischemia
risk
fact
report
death
myocardi
infarct
delay
releas
solut
gener
use
solut
also
result
platelet
activ
releas
proinflammatori
mediat
methemoglobinemia
color
interfer
laboratori
test
